During cardiovascular disease, FBLN2 has also been identified in the wall of the aorta, contributing to the ECM pool and mediating changes in the aortic wall structure upon injuries, such as thoracic aortic aneurysm [25]. Here, FBLN2 is linked to cardiovascular disorder.